Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.

The stem and progenitor cell compartments in low and intermediate-risk myelodysplastic syndromes (MDS) have recently been described, and shown to be highly conserved when compared to those in acute myeloid leukemia (AML). Much less is known about the characteristics of the hematopoietic hierarchy of...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Dimitriou, M, Woll, P, Mortera-Blanco, T, Karimi, M, Wedge, D, Doolittle, H, Douagi, I, Papaemmanuil, E, Jacobsen, S, Hellström-Lindberg, E
Natura:	Journal article
Lingua:	English
Pubblicazione:	Impact Journals 2016

Documenti analoghi

Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome
di: M A Pimenova, et al.
Pubblicazione: (2013-07-01)

A rare case of Fanconi’s anaemia with Myelodysplastic syndrome and complex cytogenetic abnormalities-Monosomy 7 and Down’s syndrome-A case report
di: Rama H, et al.
Pubblicazione: (2014-08-01)

Progression in patients with low- and intermediate1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.
di: Scharenberg, C, et al.
Pubblicazione: (2016)

Myelodysplastic syndromes
di: Eva Hellström Lindberg
Pubblicazione: (2018-06-01)

A Child with Psoriasis, Hypogammaglobulinemia, and Monosomy 7-Positive Myelodysplastic Syndrome
di: Namik Özbek, et al.
Pubblicazione: (2015-02-01)

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
di: Christian Scharenberg, et al.
Pubblicazione: (2017-03-01)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
di: Charles Dussiau, et al.
Pubblicazione: (2023-08-01)

Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells
di: Bingqing Luo, et al.
Pubblicazione: (2022-05-01)

Cytogenetic clonal evolution In myelodysplastic syndrome
di: Aw, Eunice Ching-Yi
Pubblicazione: (2018)

RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
di: Julie Schanz, et al.
Pubblicazione: (2015-04-01)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
di: Mohammad Faizan Zahid, et al.
Pubblicazione: (2016-12-01)

Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7
di: Victor B. Pastor, et al.
Pubblicazione: (2018-03-01)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
di: Pellagatti, A, et al.
Pubblicazione: (2009)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
di: Pellagatti, A, et al.
Pubblicazione: (2010)

Case series: Neurocognitive assessment of three siblings with SAMD9-associated monosomy 7/myelodysplastic syndrome
di: Diana L. Cohen, et al.
Pubblicazione: (2022-09-01)

CLINICAL AND CYTOGENETIC PROFILE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
di: Muneshwar Kumar, et al.
Pubblicazione: (2019-06-01)

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
di: Doolittle, H
Pubblicazione: (2017)

Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide
di: Gudrun Göhring, et al.
Pubblicazione: (2011-02-01)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
di: Pellagatti, A, et al.
Pubblicazione: (2010)

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
di: Woll, P, et al.
Pubblicazione: (2014)

FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells.
di: Buza-Vidas, N, et al.
Pubblicazione: (2011)

Myelodysplastic syndromes: moving towards personalized management
di: Eva Hellström-Lindberg, et al.
Pubblicazione: (2020-07-01)

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
di: Woll, P, et al.
Pubblicazione: (2014)

Cytogenetic description of breast fibroadenomas: alterations related solely to proliferation?
di: R.R. Burbano, et al.
Pubblicazione: (2001-08-01)

Molecular Cytogenetics Of Myelodysplastic Syndrome – Hospital Based Study
di: Isa, Asmida
Pubblicazione: (2014)

Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome
di: M. N. Pautova, et al.
Pubblicazione: (2024-09-01)

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
di: Yasser Elnahass, et al.
Pubblicazione: (2018-03-01)

ETV6 deletion is a common additional abnormality in patients with myelodysplastic syndromes or acute myeloid leukemia and monosomy 7
di: Meaghan Wall, et al.
Pubblicazione: (2012-12-01)

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
di: Mohsen Karimi, et al.
Pubblicazione: (2015-06-01)

Erythroid differentiation enhances RNA mis-splicing in SF3B1-mutant myelodysplastic syndromes with ring sideroblasts
di: Moura, PL, et al.
Pubblicazione: (2023)

IMPACT PROGNOSIS OF CYTOGENETIC ALTERATIONS IN BRAZILIAN CHILDHOOD MYELODYSPLASTIC NEOPLASM
di: Viviane Lovatel, et al.
Pubblicazione: (2023-12-01)

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes
di: Minh Phuong Vu, et al.
Pubblicazione: (2022-01-01)

Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
di: Sílvia Saumell, et al.
Pubblicazione: (2015-01-01)

Cystic Hygroma and Monosomy X
di: Aykut Özek, et al.
Pubblicazione: (2013-04-01)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
di: Pellagatti, A, et al.
Pubblicazione: (2013)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
di: Pellagatti, A, et al.
Pubblicazione: (2017)

Trisomy Chromosome 6 as a Sole Cytogenetic Abnormality in Acute Myeloid Leukemia
di: Monika Gupta, et al.
Pubblicazione: (2015-02-01)

Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo [Cancer Cell, 25 (2014) 794-808]
di: Woll, P, et al.
Pubblicazione: (2014)

PB1996: CYTOGENETIC FEATURES OF 164 MOROCCAN PATIENTS WITH MYELODYSPLASTIC SYNDROME
di: Yossra Aghoutane, et al.
Pubblicazione: (2023-08-01)

Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification
di: Rafia Mahmood, et al.
Pubblicazione: (2018-05-01)